RELX posted strong first-half 2026 results with underlying revenue up 7% to £4.871 billion and adjusted operating profit up 9%, lifting the margin to 35.5% as all divisions contributed; adjusted EPS rose about 11% and the interim dividend increased 7% to 20.9p. Management emphasized broad-based growth across Risk, Scientific, Technical & Medical, Legal and Exhibitions, continued AI-driven product enhancements, and active capital returns including £103 million of acquisitions and a £2.25 billion buyback, while reaffirming a strong full-year outlook amid robust cash generation and a net debt/EBITDA of 2.3x.
